A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancer

Journal of Medical Genetics

Volumn 37, Issue 3, 2000, Pages 192-196

  Gray, Jonathon ^a   Sampson, Julian ^a   Roberts, Elizabeth ^d   Newcombe, Robert ^a   Cohen, David ^c   Rogers, Cerilan ^d   Mansel, Robert ^a   Harper, Peter ^a   Brain, Kate ^a   Norman, Paul ^b   Anglim, Cathy ^a   France, Liz ^a   Barton, Garry ^c   Branston, Lucy ^d   Parsons, Evelyn ^a   Clarke, Angus ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF GLAMORGAN   (United Kingdom)

^d Breast Test Wales   (United Kingdom)

Author keywords

Breast cancer; Family history; Genetic assessment

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENETIC COUNSELING; GENETIC PROCEDURES; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY;

EID: 0034097258     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.37.3.192     Document Type: Article

References (20)

1. McPherson K, Steel CM, Dixon JM. Breast cancer - epidemiology, risk factors and genetics. BMJ 1994;309:1003-6.
2. Andersen DE. A genetic study of human breast cancer. J Natl Cancer Inst 1972;48:1029-34.
3. Eeles R. Testing for the breast cancer predisposition gene BRCA1. BMJ 1996;313:572.
4. King MC, Rowell S, Love SM. Inherited breast and ovarian cancers, what are the risks? What are the choices? JAMA 1993;269:1975-80.
5. Hall JM, Lee MK, Newman B, et al. Linkage of early onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
6. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1. Science 1994;266:66-71.
7. Easton DF, Bishop DT, Ford D, Crockford GP, and the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
8. Wooster R, Neuhausen S, Mangion J, et al. Localisation of a breast cancer susceptibility gene BRCA2 to chromosome 13q12-13. Science 1994;265:2088-90.
9. Struewing JP, Abehovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995;11:198-200.
10. Calman Hine Report. A policy framework for commissioning cancer services. Report by the expert advisory group on cancer to the Chief Medical Officers of England and Wales. London: Department of Health and Welsh Office, 1995.
11. Campbell H, Mackay J, Porteous M. The future of breast and ovarian cancer clinics. BMJ. 1995;311:1584-5.
12. Genetics and Cancer Services, Report of a Working Group for the Department of Health, 1998.
13. Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 1994;154:609-16.
14. Lynch HT, Watson P, Conway TA, et al. DNA screening for breast/ovarian cancer susceptibility based on linked markers. Arch Intern Med 1993;153:1979-87.
15. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991;48:232-42.
16. Chapman CJ. Cyrillic for pedigree drawing. Oxford: Cherwell Scientific Publishing, 1997.
17. IHA/WFN. Guidelines for the molecular genetic predictive test in Huntington's disease. J Med Genet 1994;31:555-9.
18. Ball D, Harper PS. Presymptomatic testing for late onset genetic disorders: lessons from Huntington's disease. FASEB J 1992;6:2818-19.
19. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates, 1988.
20. Drummond M, Stoddart G, Torrance G. Methods for the economic evaluation of health care programs. Oxford: Oxford Medical Publications, 1997.